NDC 10122-104

FERRIPROX

Deferiprone

FERRIPROX is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Deferiprone.

Product ID10122-104_287670b2-60ba-4095-9fe3-7fab114bfc64
NDC10122-104
Product TypeHuman Prescription Drug
Proprietary NameFERRIPROX
Generic NameDeferiprone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-05-19
Marketing CategoryNDA / NDA
Application NumberNDA212269
Labeler NameChiesi USA, Inc.
Substance NameDEFERIPRONE
Active Ingredient Strength1000 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 10122-104-01

50 TABLET in 1 BLISTER PACK (10122-104-01)
Marketing Start Date2020-05-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10122-104-01 [10122010401]

FERRIPROX TABLET
Marketing CategoryNDA
Application NumberNDA212269
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-19

Drug Details

NDC Crossover Matching brand name "FERRIPROX" or generic name "Deferiprone"

NDCBrand NameGeneric Name
10122-100FERRIPROXdeferiprone
10122-101FERRIPROXdeferiprone
10122-103FERRIPROXDEFERIPRONE
10122-104FERRIPROXdeferiprone
52609-0006FERRIPROXdeferiprone
52609-0007FERRIPROXdeferiprone
52609-4502FERRIPROXdeferiprone
0054-0576DeferiproneDeferiprone
0054-0711DeferiproneDeferiprone
51672-4196DeferiproneDeferiprone

Trademark Results [FERRIPROX]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FERRIPROX
FERRIPROX
75719191 2550510 Live/Registered
APOTEX INC.
1999-05-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.